Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Dec;22(12):1609-17.
doi: 10.1177/2047487314550803. Epub 2014 Sep 17.

Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial

Mohammad Reza Ostovaneh  1 , Hossein Poustchi  2 , Karla Hemming  3 , Hajiamin Marjani  4 , Akram Pourshams  2 , Alireza Nateghi  2 , Masoud Majed  2 , Behrouz Navabakhsh  2 , Masoud Khoshnia  4 , Elham Jaafari  2 , Noushin Mohammadifard  5 , Fatemeh Malekzadeh  2 , Shahin Merat  2 , Masoumeh Sadeghi  6 , Mohammad Naemi  4 , Arash Etemadi  7 , G Neil Thomas  3 , Nizal Sarrafzadegan  5 , K K Cheng  3 , Tom Marshall  3 , Reza Malekzadeh  8
Affiliations
Randomized Controlled Trial

Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial

Mohammad Reza Ostovaneh et al. Eur J Prev Cardiol. 2015 Dec.

Abstract

Background: The complexity of treatment regimens, costs and pill burden decrease the medication adherence and contribute to shortfall in cardiovascular preventive drug coverage. The polypill, a fixed dose combination pill of established drugs, is expected to increase adherence and reduce the costs whilst preventing major cardiovascular events (MCVE).

Design and methods: The PolyIran trial is a pragmatic cluster randomized trial nested within the Golestan Cohort Study (GCS). Subjects were randomized to either non-pharmacological preventive interventions alone (minimal care arm) or together with a polypill (polypill arm) comprising hydrochlorothiazide, aspirin, atorvastatin and either enalapril or valsartan. This study benefits from the infrastructure of the primary health care system in Iran and the interventions are delivered by the local auxiliary health workers (Behvarz) to the participants. The primary outcome of the study is the occurrence of first MCVE within five years defined as non-fatal and fatal myocardial infarction, unstable angina, sudden death, heart failure, coronary artery revascularization procedures, and non-fatal and fatal stroke.

Trial status: From February 2011 to April 2013, 8410 individuals (236 clusters) attended the eligibility assessment. Of those, 3421 in the polypill arm and 3417 in the minimal care arm were eligible. The study is ongoing.

Conclusion: The infrastructure of GCS and the primary health care system in Iran enabled the conduct of this pragmatic large-scale trial. If the polypill strategy proves effective, it may be implemented to prevent cardiovascular disease in developing countries.

Keywords: Cardiovascular diseases; polypill; primary prevention; secondary prevention.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest disclosure: No conflict of interest exists in relation to the submitted manuscript.

Figures

Figure 1
Figure 1
The trial Profile
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2013;380:2224–60. - PMC - PubMed
    1. Non-communicable diseases (NCD) WHO; 2012. Available from: http://www.who.int/gho/ncd/en/index.html.
    1. Law M, Wald N, Morris J. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess. 2003;7:1–94. - PubMed
    1. Antithrombotic Trialists’Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86. - PMC - PubMed
    1. Mendis S, Fukino K, Cameron A, et al. The availability and affordability of selected essential medicines for chronic diseases in six low-and middle-income countries. Bull World Health Organ. 2007;85:279–88. - PMC - PubMed

Publication types

MeSH terms